References
- Aguilar A, Camacho JR, Chino S, Jácquez P, López ME (1994): Herbario Medicinal del Instituto Mexicano del Seguro Social, México, Instituto Mexicano del Seguro Social, pp. 98, 99.
- Aktan F (2001): iNOS-mediated nitric oxide production and its regulation. Life Sci 75: 639–653. [CSA]
- Bailey NTJ (1995): Statistical Methods in Biology. Cambridge, Cambridge University Press, pp. 234–236.
- Castillo EP, Monroy-Ortíz C (2000): Plantas Medicinales Utilizadas en el Estado de Morelos, Cuernavaca, Morelos, México, Centro de Investigaciones Biológicas, Universidad Autónoma del Estado de Morelos, pp. 26, 34, 55, 154, 173.
- CIE-X (Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud), Décima Revisión (1995). Organización Panamericana de la Salud/Organización Mundial de la Salud.
- Daniel WW (2002): Bioestadística, Base para el análisis de las ciencias de la salud, 4th ed. México, Limusa, pp. 295–399.
- Delgado G, Hernández J, Chávez MI, Álvarez L, Gonzaga V, Martínez E (1994): Di- and triterpenoid acids from Lepechinia caulescens.. Phytochemistry 37: 1119–1121. [CROSSREF], [CSA]
- Delgado G, Sánchez E, Hernández J, Chávez MI, Álvarez L, Martínez E (1992): Abietanoid acids from Lepechinia caulescens.. Phytochemistry 31: 3159–3161. [CROSSREF], [CSA]
- Gerber JG, Nies AS (1991): Antihypertensive agents and the drugs therapy of hypertension. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. pp. 784–785.
- Ignarro LJ (1992): Haem-dependent activatin of cytosolic guanylate cyclase by nitric oxide: A widespread signal transduction mechanism. Biochem Soc T 41: 465–469. [CSA]
- INEGI/Secretaría de Salud (2002): Dirección general de información en salud. CONAPO, Proyecciones de la población de México, 2000–2050.
- Moncada S, Higgs A, Furchgott R (1997): XIV. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 49: 137–142. [PUBMED], [INFOTRIEVE], [CSA]
- Rodríguez-López V, Salazar L, Estrada S (2003): Spasmolytic activity of several extracts obtained from some Mexican medicinal plants. Fitoterapia 74: 725–728. [CROSSREF], [CSA]
- Román-Ramos R, Contreras-Weber CC, Nohpal-Grajeda G, Flores-Saenz JL, Alarcón-Aguilar FJ (2001): Blood glucose level decrease caused by extracts and fractions from Lepechinia caulescens. in healty and alloxan-diabetic mice. Pharm Biol 39: 317–321. [CSA]
- Sardana S, Madan AK (2003): Topological models for prediction of antihypertensive activity of substituted benzylimidazoles. J Mol Struct 638: 41–49. [CSA]
- Somova LI, Shode FO, Ramnanan P, Nadar A (2003a): Antihypertensive, antiaatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea., subspecies africana. leaves. J Ethnopharmacol 84: 299–305. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Somova LO, Nadar A, Rammanan P, Shode FO (2003b): Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 10: 115–121. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Testai L, Silvio C, Ammar B, Luisa P, Vincenzo C, Martinotti E (2005): Vasorelaxant effects of the chloroformic crude extract of Bupleurum fruticosum. L. (Umbelliferae) roots on rat thoracic aorta. J Ethnopharmacol 96: 93–97. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vanhoutte PM (2001): Endothelial adrenoceptors. J Cardiovasc Pharmacol 38: 796–808. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Villalobos-Molina R, Ibarra M (1996) α-Adrenoreceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the α.1D or α.1A subtypes. Eur J Pharmacol 298: 257–263. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zenteno R, Chavez R, Portugal D, Paez A, Lascurain R, Zenteno E (1995): Purification of a N-acetyl-D-galactosamine specific lectin from the orchid Laelia autumnalis.. Phytochemistry 40: 651–656. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]